Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings
about
Nurse-Led Medicines' Monitoring for Patients with Dementia in Care Homes: A Pragmatic Cohort Stepped Wedge Cluster Randomised TrialBenzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data.Antipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study.Psychotropic Drug-Related Fall Incidents in Nursing Home Residents Living in the Eastern Part of The NetherlandsCan authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications.Trends in treatment with antipsychotic medication in relation to national directives, in people with dementia - a review of the Swedish contextEffects of a geriatric intervention aiming to improve quality care in nursing homes on benzodiazepine use and discontinuation.Clinicians' prescription preferences for treating patients with Alzheimer's disease in Shanghai.Potentially inappropriate medications in elderly ambulatory and institutionalized patients: an observational study.The importance of pain management in older people with dementia.Antipsychotic prescription amongst hospitalized patients with dementia.Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD-a factorial cluster randomised controlled trial.A Review of Adverse Outcomes Associated with Psychoactive Drug Use in Nursing Home Residents with Dementia.Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.Clinical response in a risperidone-medicated naturalistic sample: patients' characteristics and dose-dependent pharmacokinetic patterns.Geographical Variation in Antipsychotic Drug Use in Elderly Patients with Dementia: A Nationwide Study.The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study.Behavioral and psychological symptoms and psychotropic drugs among people with cognitive impairment in nursing homes in 2007 and 2013.Trends, correlates, and disease patterns of antipsychotic use among elderly persons in Taiwan.Compliance of psychotropic drug prescription with clinical practice guidelines in older inpatients.Time trends in antipsychotic drug use in patients with dementia: a nationwide study.Antipsychotic use in dementia patients in a general practice setting: a Dutch population-based study.Antipsychotic Use in Dementia.Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010.Potentially inappropriate prescriptions for elderly people taking antidepressant: comparative tools.Antipsychotics use: 2006-2013 trends in prevalence and incidence and characterization of users.Use of antipsychotics and benzodiazepines for dementia: Time for action? What will be required before global de-prescribing?Change in psychotropic drug use in Norwegian nursing homes between 2004 and 2011.
P2860
Q28550194-47506A54-894D-4909-AF50-B662AD549AE1Q31154313-175312A2-B9C3-45D7-81D3-9C47949BD992Q33604532-6534AAE2-3128-40A3-BA9A-F563D2EDE1B0Q33665181-3DD81B99-6DDF-409B-BF37-A3417D14E773Q33816182-8CABC741-B276-4A55-AC1F-FF892CAF6A2FQ33910629-57B99E88-6B8D-4351-874C-B784025DD1A1Q36706773-7B584201-E561-4E96-8377-7730C947D304Q36830837-F07AC4F8-EEB3-4A61-A928-821F2A7F9201Q37192588-E0B7A4A6-D3A3-4C1D-9EFE-6F797921A6B2Q38246242-CA108E34-C2F5-43C7-B673-1F296C990632Q38774895-17CECDFC-614C-41C9-8987-489EAFB56E8DQ38957896-FE2FD288-017A-4CE6-BD14-3B368FC5E02BQ38998448-ED31E185-C404-475A-8796-2367DBBFDF11Q39115650-60D30EA6-C7B5-4B6E-BF02-FC2C558D1962Q39329159-000847CE-653A-4E92-A1BE-E44B08498DB5Q39446994-9F28AF08-3DF9-414E-8F41-67B3900C34FFQ39595929-03F00572-1DAD-42DC-AC49-CBAB16025074Q39855970-3EEB7CC8-E3A4-4D8D-8C15-DE784E9F0751Q40211664-342ADA2B-C668-430D-9CCE-BF14C9191E98Q40336391-CE2F57FA-4FB3-463D-B12C-0B273D5F4A8FQ40457871-84B5E141-D77B-49A4-9609-D2579DF13F47Q40847123-DD42E976-C491-44CB-BE7E-DF5A4565217DQ41827089-2B46C9E6-F1FF-494E-AD6A-D783403FB947Q43625820-122B1BAE-B9EC-4BE1-8781-6628CB6ED6B8Q47380529-A00B09A7-B79A-488D-AAB8-9CA2B8877A93Q48299118-15E1E6C2-0172-4067-847E-E534F3975CC4Q48358619-DDB461F3-E3A2-4A04-8C9D-39FD26C0890EQ49499746-8422D640-24A4-4E0C-B9FA-2B058386557C
P2860
Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Trends in use of antipsychotic ...... ct of national safety warnings
@ast
Trends in use of antipsychotic ...... ct of national safety warnings
@en
type
label
Trends in use of antipsychotic ...... ct of national safety warnings
@ast
Trends in use of antipsychotic ...... ct of national safety warnings
@en
prefLabel
Trends in use of antipsychotic ...... ct of national safety warnings
@ast
Trends in use of antipsychotic ...... ct of national safety warnings
@en
P2093
P2860
P50
P1476
Trends in use of antipsychotic ...... ct of national safety warnings
@en
P2093
Adeline Gallini
Naïma Oumouhou
Sandrine Andrieu
P2860
P304
P356
10.1016/J.EURONEURO.2013.09.003
P407
P577
2013-09-17T00:00:00Z